Selected Publications (2004)

Mikyas, Y., Makabi, M., Raval-Fernandes, S., Harrington, L., Kickhoefer, V. A., Rome, L.H. and Stewart P. L. (2004) Cryoelectron Microscopy Imaging of Recombinant and Tissue Derived Vaults: Localization of the MVP N Termini and VPARP. J. Mol. Biol. 344, 91-105.

Emre, N. Raval-Fernandes, S. Kickhoefer, V.A. and Rome, L.H. (2004) Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP. Biochim Biophys Acta. 1678, 33-46.

Liu, Y., Snow, B.E., Kickhoefer, V.A., Erdmann, N., Zhou, W., Wakeham, A., Gomez, W., Rome L.H. and Harrington L. (2004) Vault protein VPARP is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol. Cell. Biol. 12, 5314-5323.

Kolli, S., Zito, C.I., Mossink, M.H., Wiemer, E.A. and Bennett, A.M. (2004) The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 279, 29374–29385.

Krull, J. Thyberg, B. Bjorkroth, H.R. Rackwitz and V.C. Cordes, (2004) Nucleoporins as components of the nuclear pore complex core structure and tpr as the architectural element of the nuclear basket. Molecular Biology of the Cell 15, 4261–4277.

Stam RW, van den Heuvel-Eibrink MM, den Boer ML, Ebus ME, Janka-Schaub GE, Allen JD, Pieters R. (2004) Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein. Leukemia 18, 78-83.

Steiner, E., Holzmann, K., Pirker, C., Elbling, L., Micksche, M. and Berger, W. (2004). SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. Biochem. Biophys. Res. Commun. 317, 235-243.

van Zon A, Mossink MH, Schoester M, Scheper RJ, Sonneveld P, Wiemer EA. (2004) Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer Res. 64, 4887-4892.